Literature DB >> 32196629

Circular RNA TTBK2 regulates cell proliferation, invasion and ferroptosis via miR-761/ITGB8 axis in glioma.

H-Y Zhang1, B-W Zhang, Z-B Zhang, Q-J Deng.   

Abstract

OBJECTIVE: Glioma is a primary intracranial tumor with an unfavorable prognosis. Evolving evidence indicates that circular RNA Tau tubulin kinase 2 (circ-TTBK2) is a cancer-associated gene. Therefore, this study was to explore the potential role of circ-TTBK2.
MATERIALS AND METHODS: Levels of circ-TTBK2, microRNA (miR)-761, and integrin subunit beta 8 (ITGB8) were determined by adopting quantitative real-time polymerase chain reaction (qRT-PCR) or Western blot. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was performed to detect cell viability, and the invaded cells were distinguished utilizing transwell assay. Iron and lipid reactive oxygen species (ROS) assays were implemented to examine the iron (total iron and ferrous iron) and lipid-based ROS in glioma cells, respectively. Besides, dual-luciferase reporter assay was administrated to illustrate the interaction between miR-761 and circ-TTBK2 or ITGB8. The role of circ-TTBK2 was identified via xenograft tumor model.
RESULTS: Levels of circ-TTBK2 and ITGB8 were upregulated, whereas miR-761 level was low-expressed in glioma tissues and cells. Circ-TTBK2 was a sponge of miR-761 to modulate ITGB8. Additionally, circ-TTBK2 knockdown or miR-761 increase could retard cell proliferation, invasion, and promote ferroptosis in glioma cells. Interestingly, miR-761 inhibitor could abolish the repressive impact of circ-TTBK2 silencing on cell growth in vitro. Also, the influence of miR-761 mimic on cell phenotypes was regained after ITGB8 upregulation. Meanwhile, circ-TTBK2 deficiency caused the decrease of tumor growth.
CONCLUSIONS: Circ-TTBK2 regulated cell proliferation, invasion and ferroptosis via targeting ITGB8 by sponging miR-761 in glioma, providing a promising biomarker for the clinical therapy of human glioma.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32196629     DOI: 10.26355/eurrev_202003_20528

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  31 in total

Review 1.  Non-coding RNAs in ferroptotic cancer cell death pathway: meet the new masters.

Authors:  Mehdi Rabiee Valashedi; Chia Bamshad; Nima Najafi-Ghalehlou; Amirsadegh Nikoo; Kazuo Tomita; Yoshikazu Kuwahara; Tomoaki Sato; Amaneh Mohammadi Roushandeh; Mehryar Habibi Roudkenar
Journal:  Hum Cell       Date:  2022-04-12       Impact factor: 4.174

2.  CircRNA-ST6GALNAC6 increases the sensitivity of bladder cancer cells to erastin-induced ferroptosis by regulating the HSPB1/P38 axis.

Authors:  Li Wang; Shuiqing Wu; Haiqing He; Kai Ai; Ran Xu; Lei Zhang; Xuan Zhu
Journal:  Lab Invest       Date:  2022-08-09       Impact factor: 5.502

Review 3.  Ferroptosis Modulation: Potential Therapeutic Target for Glioblastoma Treatment.

Authors:  Izadora de Souza; Maria Carolina Clares Ramalho; Camila Banca Guedes; Isabeli Yumi Araújo Osawa; Linda Karolynne Seregni Monteiro; Luciana Rodrigues Gomes; Clarissa Ribeiro Reily Rocha
Journal:  Int J Mol Sci       Date:  2022-06-21       Impact factor: 6.208

Review 4.  Regulatory pathways and drugs associated with ferroptosis in tumors.

Authors:  Dan Wang; Le Tang; Yijie Zhang; Guili Ge; Xianjie Jiang; Yongzhen Mo; Pan Wu; Xiangying Deng; Lvyuan Li; Sicheng Zuo; Qijia Yan; Shanshan Zhang; Fuyan Wang; Lei Shi; Xiayu Li; Bo Xiang; Ming Zhou; Qianjin Liao; Can Guo; Zhaoyang Zeng; Wei Xiong; Zhaojian Gong
Journal:  Cell Death Dis       Date:  2022-06-10       Impact factor: 9.685

Review 5.  Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer.

Authors:  Xuan Liu; Yiqian Zhang; Xuyi Wu; Fuyan Xu; Hongbo Ma; Mengling Wu; Yong Xia
Journal:  Front Pharmacol       Date:  2022-06-30       Impact factor: 5.988

6.  The abnormal expression of circ-ARAP2 promotes ESCC progression through regulating miR-761/FOXM1 axis-mediated stemness and the endothelial-mesenchymal transition.

Authors:  Pei Xu; Lei Wang; Qingtao Liu; Pengkai Gao; Fengqing Hu; Xiao Xie; Lianyong Jiang; Rui Bi; Fangbao Ding; Qi Yang; Haibo Xiao
Journal:  J Transl Med       Date:  2022-07-16       Impact factor: 8.440

7.  Downregulation of circ_0037655 impedes glioma formation and metastasis via the regulation of miR-1229-3p/ITGB8 axis.

Authors:  Wenhui Zou; Yalei Cao; Kai Cheng; Changyu Li; Fu Zhu; Shumao Yang; Maolin Jin; Shaojun Song
Journal:  Open Life Sci       Date:  2021-05-10       Impact factor: 0.938

8.  MiR-424-5p Inhibits Proliferation, Invasion and Promotes Apoptosis and Predicts Good Prognosis in Glioma by Directly Targeting BFAR.

Authors:  Zhe Cheng; Hansheng Shu; Ying Cui; Qiujian Zhang; Biao Zhao; Didi Pan; Qing Chao; Dawei Wang
Journal:  Pathol Oncol Res       Date:  2020-06-01       Impact factor: 3.201

9.  Circ-SPG11 knockdown hampers IL-1β-induced osteoarthritis progression via targeting miR-337-3p/ADAMTS5.

Authors:  Yongqiang Liu; Qian Li; Zhida Gao; Fang Lei; Xuefeng Gao
Journal:  J Orthop Surg Res       Date:  2021-06-17       Impact factor: 2.359

Review 10.  Emerging mechanisms and targeted therapy of ferroptosis in cancer.

Authors:  Haiyan Wang; Yan Cheng; Chao Mao; Shuang Liu; Desheng Xiao; Jun Huang; Yongguang Tao
Journal:  Mol Ther       Date:  2021-03-29       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.